Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 2027-2037

  Zhuo, Jialong ^a   Moeller, Ingrid ^a   Jenkins, Trisha ^a   Chai, Siew Yeen ^a   Allen, Andrew M ^a   Ohishi, Mitsuru ^a   Mendelsohn, Frederick A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Angiotensin IV; Angiotensin converting enzyme; AT1 receptor; AT4 receptor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 4 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ELECTROLYTE; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ADVENTITIA; AUTORADIOGRAPHY; BLOOD PRESSURE REGULATION; BLOOD VESSEL; BODY FLUID; CAUDATE NUCLEUS; CELL GROWTH; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; CONFERENCE PAPER; DOPAMINE METABOLISM; DOPAMINE RELEASE; ELECTROLYTE BALANCE; ENDOCRINE SYSTEM; FLUID BALANCE; HEMODYNAMICS; KIDNEY; KIDNEY MEDULLA; LEYDIG CELL; MEMORY; MORPHOLOGY; MOTONEURON NUCLEUS; NERVE CELL; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUTAMEN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSORY NERVE; SUBSTANTIA NIGRA;

EID: 0032427881     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00026     Document Type: Conference Paper

References (102)

1. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-251.
2. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991; 351:233-236.
3. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995; 377:744-747.
4. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, et al.: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991; 351:230-233.
5. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, et al.: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377:748-750.
6. Phillips MI: Functions of angiotensin in the central nervous system. Annu Rev Physiol 1987; 49:413-435.
7. Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57:313-370.
8. Baker KM, Booz GW, Dostal DE: Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992; 54:227-241.
9. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996; 76:425-536.
10. Holtz J, Goetz RM: Vascular renin-angiotensin-system, endothelial function and atherosclerosis? Basic Res Cardiol 1994; 89 (suppl 1):71-86.
11. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA: Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 1991; 18:III126-III133.
12. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA: Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28:104-108.
13. Wright JW, Krebs LT, Stobb JW, Harding JW: The angiotensin IV system: functional implications. Front Neuroendocrinol 1995; 16:23-52.
14. Ardaillou R, Chansel D: Angiotensin IV, a new component of the renin-angiotensin system, which acts on kidney cells. Bull Acad Natl Med 1996; 180:475-486.
15. Gardiner SM, Kemp PA, March JE, Bennett T: Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 1993; 110:159-162.
16. Cheng DY, DeWitt BJ, Dent EL, Nossaman BD, Kadowitz PJ: Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 261:223-227.
17. Nossaman BD, Feng CJ, Kaye AD, Kadowitz PJ: Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. Am J Physiol 1995; 268:L302-L308.
18. Miller Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Wright JW, Speth RC, et al.: Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 1993; 266:1718-1726.
19. Moeller I, Chai SY, Oldfield BJ, McKinley MJ, Casley D, Mendelsohn FA: Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hindbrain. Brain Res 1995; 701:301-306.
20. 4 receptors in the Macaca fascicularis brain. Brain Res 1996; 712:307-324.
21. Wright JW, Miller Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW: Angiotensin II (3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 1993; 32:497-502.
22. 4-receptor system in the rat kidney. Am J Physiol 1998; 274:F290-F299.
23. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW: Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol EKP Ther 1993; 266:1036-1042.
24. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, et al.: Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 1992; 40:409-419.
25. Zhuo J, Allen AM, Alcorn D, Aldred GP, MacGregor DP, Mendelsohn FAO: The distribution of angiotensin II receptors. In: Laragh JH, Brenner BM (editors). Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press; 1995. pp. 1739-1762.
26. Zhuo J, Allen AM, Yamada H, Sun Y, Mendelsohn FAO: Localization and properties of the angiotensin-converting enzyme and angiotensin receptors in the heart. In: Lindpaintner K, Ganten D (editors). The Cardiac-Renin Angiotensin System. New York: Futura; 1994. pp. 63-88.
27. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FAO: Angiotensin receptors in the nervous system. Brain Res Bull 1998; 47:17-28.
28. Chai SY, Johnston CI: Tissue distribution of angiotensin converting enzyme. In: Laragh JH, Brenner BM (editors). Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press; 1995. pp. 1683-1693.
29. Unger T, Chung O, Csikos T, Culman J, Gallinat S, et al.: Angiotensin receptors. J Hypertens 1996; 14 (suppl):S95-S103.
30. Chai SY, Mendelsohn FA, Paxinos G: Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 1987; 20:615-627.
31. Chai SY, McKinley MJ, Paxinos G, Mendelsohn FA: Angiotensin converting enzyme in the monkey (Macaca fascicularis) brain visualized by in vitro autoradiography. Neuroscience 1991; 42:483-495.
32. Chai SY, McKenzie JS, McKinley MJ, Mendelsohn FA: Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography. J Comp Neurol 1990; 291:179-194.
33. Lind RW, Swanson LW, Ganten D: Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat. Brain Res 1984; 321:209-215.
34. Lind RW, Swanson LW, Ganten D: Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. Neuroendocrinology 1985; 40:2-24.
35. Song K, Allen AM, Paxinos G, Mendelsohn FA: Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol 1992; 316:467-484.
36. Saavedra JM: Brain and pituitary angiotensin. Endocr Rev 1992; 13:329-380.
37. Jenkins TA, Mendelsohn FA, Chai SY: Angiotensin converting enzyme modulates dopamine turnover in the striatum. J Neurochem 1997; 68:1304-1311.
38. Ganong WF: Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol 1993; 14:233-249.
39. Gehlert DR, Gackenheimer SL, Schober DA: Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain. Neuroscience 1991; 44:501-514.
40. Aldred GP, Chai SY, Song K, Zhuo J, MacGregor DP, Mendelsohn FA: Distribution of angiotensin II receptor subtypes in the rabbit brain. Regul Pept 1993; 44:119-130.
41. MacGregor DP, Murone C, Song K, Allen AM, Paxinos G, Mendelsohn FA: Angiotensin II receptor subtypes in the human central nervous system. Brain Res 1995; 675:231-240.
42. Barnes JM, Steward LJ, Barber PC, Barnes NM: Identification and characterisation of angiotensin II receptor subtypes in human brain. Eur J Pharmacol 1993; 230:251-258.
43. 2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J Biol Chem 1995; 270:1670-1674.
44. Sumners C, Tang W, Zelezna B, Raizada MK: Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 1991; 88:7567-7571.
45. 2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 1997; 18:383-439.
46. Allen AM, Chai SY, Clevers J, McKinley MJ, Paxinos G, Mendelsohn FA: Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata. J Comp Neurol 1988; 269:249-264.
47. Allen AM, MacGregor DP, Chai SY, Donnan GA, Kaczmarczyk S, Richardson K, et al.: Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol 1992; 32:339-344.
48. Allen AM, Paxinos G, McKinley MJ, Chai SY, Mendelsohn FA: Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain pons, and cerebellum. J Comp Neurol 1991; 312:291-298.
49. Mendelsohn FA, Jenkins TA, Berkovic SF: Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 1993; 613:221-229.
50. 1 receptor subtype in cardiovascular function. Peptides 1996; 17:1365-1371.
51. Campbell DJ: Angiotensin peptides in the brain. Adv Exp Med Biol 1995; 377:349-355.
52. 4 receptor in the brain. J Neurochem 1997; 68:2530-2537.
53. Braszko JJ, Kupryszewski G, Witczuk B, Wisniewski K: Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 1988; 27:777-783.
54. Wright JW, Clemens JA, Panetta JA, Smalstig EB, Weatherly LA, et al.: Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res 1996; 717:1-11.
55. Moeller I, Small DH, Reed G, Harding JW, Mendelsohn FA, Chai SY: Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Res 1996; 725:61-66.
56. Haberl RL, Decker PJ, Einhaupl KM: Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ Res 1991; 68:1621-1627.
57. Naveri L, Stromberg C, Saavedra JM: Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 1994; 14:1096-1099.
58. Lindpaintner K, Wilhelm MJ, Jin M, Unger T, Lang RE, Schoelkens BA, Ganten D: Tissue renin-angiotensin systems: focus on the heart. J Hypertens 1987; 5 (suppl):S33-S38.
59. Schelling P, Fischer H, Ganten D: Angiotensin and cell growth: a link to cardiovascular hypertrophy? [editorial]. J Hypertens 1991; 9:3-15.
60. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-482.
61. Yamada H. Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn AO: Localization of angiotensin converting enzyme in rat heart. Circ Res 1991; 68:141-149.
62. Allen AM, Yamada H, Mendelsohn FA: In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart, Int J Cardiol 1990; 28:25-33.
63. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FA: Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992; 10:615-620.
64. Scott AL, Chang RS, Lotti VJ, Siegl PK: Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart. J Pharmacol Exp Ther 1992; 261:931-935.
65. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M: Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 1992; 71:1482-1489.
66. 2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol Suppl 1996; 3:S147-S154.
67. Ohishi M, Ueda M, Rakugi H, Okamura A, Naruko T, Becker AE, et al.: Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997; 96:3328-3337.
68. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A, et al.: Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 1997; 15:1295-1302.
69. 1 receptor mediated. Arterioscler Thromb Vasc Biol 1996; 16:857-863.
70. Keidar S, Kaplan M, Hoffman A, Aviram M: Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 1995; 115:201-215.
71. Kohzuki M, Johnston CI, Chai SY, Jackson B, Perich R, Paxton D, Mendelsohn FA: Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment. J Hypertens 1991; 9:579-587.
72. Zhuo JL, Froomes P, Casley D, Liu JJ, Murone C, Chai SY, et al.: Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Circulation 1997; 96:174-182.
73. Zhuo J, Casley D, Murone C, Mendelsohn FAO: Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit. J Cardiovasc Pharmacol 1997; 29:297-310.
74. Pipili Synetos E, Sideri E, Catravas JD, Maragoudakis ME: Endothelium removal does not abolish angiotensin converting enzyme activity from the mesenteric arterial bed of the rat. Biochem Pharmacol 1990; 40:1149-1151.
75. Boadle MC, Hughes J, Roth RH: Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature 1969; 222:987-988.
76. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA: Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995; 47:25-49.
77. de Gasparo M, Levens NR; Pharmacology of angiotensin II receptors in the kidney. Kidney Int 1994; 46:1486-1491.
78. Edwards RM, Aiyar N: Angiotensin II receptor subtypes in the kidney [editorial], J Am Soc Nephrol 1993; 3:1643-1652.
79. Zhuo J, Alcorn D, Harris PJ, McCausland J, Aldred GP, Mendelsohn FAO: Angiotensin II receptor subtypes in the kidney: distribution and function. Nephrology 1997; 1:511-525.
80. Zhuo J, Alcorn D, Allen AM, Mendelsohn FA: High resolution localization of angiotensin II receptors in rat renal medulla. Kidney Int 1992; 42:1372-1380.
81. Zhuo J, Alcorn D. Harris PJ, Mendelsohn FA: Localization and properties of angiotensin II receptors in rat kidney. Kidney Int 1993; 43 (suppl):S40-S46.
82. 1 receptor mRNA in rat kidney. Kidney Int 1994; 46:973-979.
83. Kakinuma Y, Fogo A, Inagami T, Ichikawa I: Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int 1993; 43:1229-1235.
84. 1 receptor. Am J Physiol 1993; 264:F989-F995.
85. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 1997; 273:F170-F1 77.
86. Shanmugam S, Monnot C, Corvol P, Gasc JM: Distribution of type 1 angiotensin II receptor subtype messenger RNAs in the rat fetus. Hypertension 1994; 23:137-141.
87. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, Ichikawa I: Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995; 47:140-147.
88. Butkus A, Albiston A, Alcorn D, Giles M, McCausland J, Moritz K, et al: Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros. Kidney Int 1997; 51:628-636.
89. Chansel D, Czekalski S, Pham P, Ardaillou R: Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 1992; 262:F432-F441.
90. Chatziantoniou C, Dussaule JC, Arendshorst WJ, Ardaillou R: Angiotensin II receptors and renin release in rat glomerular afferent arterioles. Kidney Int 1994; 46:1570-1573.
91. Dulin NO, Ernsberger P, Suciu DJ, Douglas JG: Rabbit renal epithelial angiotensin II receptors. Am J Physiol 1994; 267:F776-F782.
92. Zhuo J, Alcorn D, McCausland J, Casley D, Mendelsohn FA: In vivo occupancy of angiotensin II subtype 1 receptors in rat renal medullary interstitial cells. Hypertension 1994; 23:838-843.
93. 1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 1994; 21:557-567.
94. Zhuo J, Alcorn D, McCausland J, Mendelsohn FA: Localization and regulation of angiotensin II receptors in renomedullary interstitial cells. Kidney Int 1994; 46:1483-1485.
95. 1A receptors. Am J Physiol 1996; 40:F1020-F1028.
96. Bohman SO: The ultrastructure of the renal medulla and the interstitial cells. In: Mendel AK, Bohman SO (editors). The Renal Papilla and Hypertension. New York: Plenum Medical Book Co.; 1980. pp. 7-33.
97. Schlondorft D: The glomerular mesangial cells: an expanding role for a specialized pericytes. FASEB J 1987; 1:272-281.
98. Kriz W, Elger M, Lemley K, Sakai T: Structure of glomerular mesangium: a biomechanical interpretation. Kidney Int 1990; 38:S2-S9.
99. Muirhead EE, Pitcock JA: The renal antihypertensive hormone. J Hypertens 1985; 3:1-8.
100. Chansel D, Liorens-Cortes C, Vandermeersch S, Pham P, Ardaillou R: Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells. Hypertension 1996; 27:867-874.
101. Siragy HM, Howell NL, Ragsdale NV, Carey RM: Renal interstitial angiotensin: modulation by anaesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 1995; 25:1021-1024.
102. 1 receptors in the kidney: focus on renomedullary interstitial cells. Hypertens Res 1997; 20:233-250.